Catalog encodes data with chemical parallelism, running hundreds of thousands of reactions per second through its automated writer. Synthetic DNA offers extreme molecular density with stability over centuries without refresh or energy use.
The platform combines storage with parallel search and computation directly on encoded DNA. Automation and a programming framework let customers run analytics and machine learning on DNA-resident data.
Demand for long-term archival storage keeps growing as organizations retain ever-larger volumes of durable records. DNA media promise retention measured in decades with minimal footprint and low ongoing energy needs.
Commercial progress depends on writing cost, throughput, and integration with existing data infrastructure. Industry alliances are developing standards that will shape adoption of DNA storage and computation.
Catalog is a Boston enterprise focused on DNA-based storage and computation, with automation, biosecurity screening, and partnerships such as Seagate supporting its platform. Its Shannon writer and parallel search and compute research anchor the technology program.
Key assets transferred to Biomemory in 2026, extending the technology into data center deployment plans. The combination pairs Catalog storage and compute work with an industrialized DNA process under one roof.
